A pulmonary embolism (PE) is a type of venous thromboembolism ... and then travel to your pulmonary arteries. The exact treatment for PE depends on its severity and whether you need critical ...

Shatti, head of the Cardiac Catheterization Unit at Al-Dabous Center at Al-Adan Hospital, announced that the hospital has ...

Findings from the first international randomized controlled trial to compare patient outcomes following treatment with ...

Re-expansion pulmonary oedema (RPE) is an uncommon complication that occurs when a collapsed lung suddenly re-expands, resulting in an osmotic shift of fluid from the blood vessels into the air spaces ...

The National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH) recently awarded a $3.7 ...

(Nasdaq:NARI) today announced positive results from its prospective PEERLESS trial for the FlowTriever system.

Jupiter Endovascular today announced the first U.S. patient treated in its SPIRARE II U.S. pivotal study for the Vertex ...

The FlowTriever system is 510(k)-Cleared by FDA and CE Mark approved for the treatment of pulmonary embolism and clot in transit in the right atrium. Inari Medical NewsMORE Related Stocks ...

Anesthetic management of patients presenting for catheter-based embolectomy is often challenging as patients are at risk for ...

U.S. Food and Drug Administration (FDA) has approved VYLOY (zolbetuximab-clzb) in combination with fluoropyrimidine- and ...